Press Releases
Search
-
01 Mar 2005
B·R·A·H·M·S AG and bioMérieux SA sign a non-exclusive agreement on the use of Procalcitonin
Marcy l'Etoile, France - March 1st, 2005. B·R·A·H·M·S AG and bioMérieux SA have announced the signature of a non-exclusive agreement on the use of Procalcitonin as a diagnostic marker for severe bacte...
-
10 Feb 2005
bioMérieux launches VITEK® 2 Compact, its new solution for rapid identification of micro-organisms
Marcy l’Etoile, France - February 10, 2005. bioMérieux, a major player in the field of microbiological controls for the pharmaceutical and agri-food industries, introduces VITEK®2 Compact, the newest ...
-
31 Jan 2005
bioMérieux innovates in food quality testing
Marcy l'Etoile, France - January 31, 2005. bioMérieux, world leader in the field of food microbiology controls, extends its product offer dedicated to the food industry with the launch of the TEMPO® s...
-
19 Jan 2005
2004 Sales up 5.2% at Constant Exchange Rates
Marcy l'Etoile, France - January 19, 2005. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its 2004 sales.
-
06 Jan 2005
bioMérieux launches VITEK® 2 Compact to complete its VITEK 2 range
Marcy l’Etoile, France - January 6, 2005. A world leader in the field of in vitro diagnostics, bioMérieux SA (Euronext: FR0010096479 – BIM) completes its VITEK® 2 range of automated microbial identifi...
-
15 Dec 2004
bioMérieux acquires an option to license Applied NeuroSolutions’ Technology to diagnose Alzheimer’s disease
Marcy L’Etoile, France - December 15th, 2004. bioMérieux SA (Euronext: FR0010096479 – BIM) , announces today that it signed a non-exclusive agreement with Applied Neurosolutions granting bioMérieux SA...